ISTH/LinkedIn
May 19, 2026, 15:57
Explore the Emerging Science Behind Factor XI/XIa Inhibition on the ISTH Academy – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“What if stroke prevention didn’t have to come with the same level of bleeding risk?
Explore the emerging science behind factor XI/XIa inhibition in this new learning resource on the ISTH Academy.
Review the role of FXI in thrombosis and hemostasis, examine key clinical trial data and discover how these therapies may reshape secondary stroke prevention.
- Includes real-world clinical scenarios
- CME credit available upon completion
Start learning today with the ISTH Academy.”
Other posts featuring International Society on Thrombosis and Haemostasis on Hemostasis Today.
-
May 19, 2026, 15:55Highlighting Key Achievements and Critical Updates from Iran’s National Blood System – IBTO
-
May 19, 2026, 15:54Joanna Fraser: New Publications on Women and Girls With Inherited Bleeding Disorders
-
May 19, 2026, 15:53Nicolas Hubacz: Hantavirus – What You Should Know
-
May 19, 2026, 15:53John Kowal: AHA/ASA Guidelines for Early Stroke Care Now Include Mobile Stroke Units
-
May 19, 2026, 15:52Cedric Hermans: Proposing a New 3-tier Framework for FVIII Replacement Therapy in Hemophilia A
-
May 19, 2026, 15:46Armghan Ans: Striking Evidence Reversals of The Last Decade for Stroke
-
May 19, 2026, 15:01Laura Girardi: Medical Inpatients’ Thromboprophylaxis – Was It All Already Said?
-
May 19, 2026, 14:58ASH HematOmics Helps Researchers Explore Genomic Data Across Blood Diseases
-
May 19, 2026, 14:53Wolfgang Miesbach: First Lp(a)‑Specific Therapy in Secondary Prevention?